Page last updated: 2024-09-03

kb 5492 and cysteamine

kb 5492 has been researched along with cysteamine in 1 studies

Compound Research Comparison

Studies (kb 5492)	Trials (kb 5492)	Recent Studies (post-2010) (kb 5492)	Studies (cysteamine)	Trials (cysteamine)	Recent Studies (post-2010) (cysteamine)
8	0	0	3,307	60	666

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hara, H; Morimoto, Y; Shimohara, K; Sukamoto, T; Tanaka, K	1

Other Studies

1 other study(ies) available for kb 5492 and cysteamine

Article	Year
4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from t Japanese journal of pharmacology, 1994, Volume: 64, Issue:3 Topics: Animals; Anti-Ulcer Agents; Bicarbonates; Cimetidine; Cysteamine; Duodenal Ulcer; Duodenum; Gastric Acid; Intestinal Secretions; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma	1994

Article

Year

4-Methoxyphenyl 4-(3,4,5-trimethoxybenzyl)-1-piperazineacetate monofumarate monohydrate (KB-5492), a new anti-ulcer agent with a selective affinity for the sigma receptor, prevents cysteamine-induced duodenal ulcers in rats by a mechanism different from t

Japanese journal of pharmacology, 1994, Volume: 64, Issue:3

Topics: Animals; Anti-Ulcer Agents; Bicarbonates; Cimetidine; Cysteamine; Duodenal Ulcer; Duodenum; Gastric Acid; Intestinal Secretions; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma

1994